NLRP3 and epilepsy: Since the role of the NLRP3 inflammasome pathway in the pathogenesis and progression of epilepsy has been well documented, the development of NLRP3 inhibitors as a potential therapeutic target for the treatment of seizures and epilepsy is urgently needed.